According to the latest market research study by Technavio, the global immunodiagnostics market is expected to grow at a CAGR of close to 8% during the forecast period 2017 to 2021.
This report by Technavio provides an in-depth analysis of the global immunodiagnostics market in terms of revenue and emerging market trends. The report also includes an up-to-date vendor analysis and forecasts for various market segments and all geographical regions.
Technavio research analysts categorize the market based on the application
Source: Technavio
Click here to request a free sample of this report
The top three revenue contributing application segments are discussed below
Global oncology and endocrinology market: High incidence of cancer among people and the requirement of early diagnosis to provide treatment to individuals fuel the market growth. Immunodiagnostic tests that offer low-range sensitivity are currently available in the market. For instance, VITROS Total PSA Assay II from Orthoclinical Diagnostics is a prostate-specific antigen test offering analytical sensitivity along with broad measuring range to improve the monitoring and screening of patients.
“Diabetes testing accounted for the major share among all endocrinology testing procedures performed in 2015. The increasing type-1 and type-2 diabetes population due to the changes in lifestyle have led to the growth in the diabetes testing,” says Srinivas Sashidhar, a lead analyst at Technavio for research on in-vitro diagnostics.
Global hepatitis and retrovirus testing market: High occurrence of food-borne enteric viruses such as retroviruses and hepatitis A virus are major causes for public health concern. These viruses are responsible for non-bacterial gastroenteritis and infectious hepatitis in individuals, which can sometimes be fatal. Rotavirus is the most common agent of severe diarrhea among infants and children worldwide. For instance, in 2015, 350 million people were infected with chronic hepatitis B, out of these seven million people died due to complications of hepatitis B. All such rising occurrences of hepatitis fuels the growth of hepatitis and retrovirus testing market.
Global infectious disease testing market: The high instances of infectious diseases has increased the demand for diagnostic tests and new reagents in the market. Immunodiagnostic tests help diagnose infectious diseases such as materno-fetal infections, infectious mononucleosis, pneumonia, congenital rubella syndrome, chickenpox, and syphilis.
Ask an analyst to know more about this report
The top vendors operating in the global immunodiagnostics market are:
- Abbott Laboratories
- Danaher
- Roche Diagnostics
- Siemens Healthineers
The other prominent vendors in the market include Adaptive Biotechnologies, AESKU Diagnostics, Alere, Amarantus Bioscience Holdings, Autoimmune Technologies, Avant Diagnostics, Axis-Shield Diagnostics, bioMérieux, DiaSorin, ERBA Diagnostics, Euro Diagnostica, Exagen Diagnostics, Gold Standard Diagnostics, HOB Diagnostics, HUMAN Diagnostics, IMMCO, Inova Diagnostics, Myriad Genetics, Nexus Dx, Omega Diagnostics, OraSure Technologies, ORGENTEC Diagnostika, Protagen, QIAGEN, Quest Diagnostics, Samsung Electronics, Seramun Diagnostica, SQI Diagnostics, Tecan, Thermo Fisher Scientific, and Trillium Diagnostics.
A more detailed analysis is available in the Technavio report titled, ‘Global Immunodiagnostics Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports
- Global Medical Imaging Left Atrial Appendage Closure Market 2017-2021
- Global Hepatitis B and C Diagnostics Market 2016-2020
- Clinical Immunoassay Analyzer Market in the US 2016-2020
To read more press releases – click here
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
https://www.technavio.com/
